Location Oxford, Oxfordshire, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Jonathan Hopper is founder and CEO of OMass Therapeutics. Jonathan completed his PhD in native mass spectrometry under the supervision of Prof. Neil Oldham and moved to the University of Oxford to develop native mass spectrometry approaches for studying membrane proteins with Professor Dame Carol Robinson. His research was focussed on developing
technologies which enable or improve the structural/functional information obtained on challenging membrane protein assemblies and drug targets. He founded OMass with the intention of applying these technologies to pharmaceutical research. He led the company through its seed funding and recent series A financing rounds, allowing OMass to now develop its own drug discovery programmes in-house.
